Edwards Lifesciences (EW) Misses Q4 EPS by 4c, Offers Guidance
Get Alerts EW Hot Sheet
EPS Growth %: +3.2%
Financial Fact:
Gross profit: 538M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q4 EPS of $0.51, $0.04 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $1.33 billion versus the consensus estimate of $1.36 billion.
GUIDANCE:
Edwards Lifesciences sees Q1 2022 EPS of $0.54-$0.62, versus the consensus of $0.60. Edwards Lifesciences sees Q1 2022 revenue of $1.27-1.35 billion, versus the consensus of $1.36 billion.
Edwards Lifesciences sees FY2022 EPS of $2.50-$2.65, versus the consensus of $2.58. Edwards Lifesciences sees FY2022 revenue of $5.5-6 billion, versus the consensus of $5.82 billion.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Grainger (GWW) Tops Q1 EPS by 2c, provides guidance
- OSI Systems (OSIS) Tops Q3 EPS by 6c
- HarborOne Bancorp, Inc. (HONE) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!